Canrenoic acid is a steroidal antimineralocorticoid that functions as a potent aldosterone antagonist and potassium-sparing diuretic, widely utilized in the treatment of hypertension, edema, and heart… Read more
Canrenoic acid is a steroidal antimineralocorticoid that functions as a potent aldosterone antagonist and potassium-sparing diuretic, widely utilized in the treatment of hypertension, edema, and heart failure. As the active metabolite of spironolactone and potassium canrenoate, it plays a critical role in managing fluid retention and electrolyte balance. The category features high-quality reference standards for canrenoic acid, including essential pharmaceutical impurities, degradation products, and stable isotope-labeled compounds. These materials are vital for pharmaceutical laboratories engaged in rigorous analytical testing, method validation, and stability studies. By providing accurate benchmarks for impurity profiling and quantitative analysis, these reference compounds help ensure the safety, efficacy, and quality control of pharmaceutical formulations throughout the drug development lifecycle. Laboratories rely on these materials to maintain compliance with regulatory standards and to support precise pharmacokinetic assessments of aldosterone receptor antagonists.